Apr 12 |
Top 3 Health Care Stocks That May Collapse In Q2
|
Apr 12 |
Revolution Medicines: An Expensive Shot At A Massive Market Opportunity
|
Apr 10 |
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
|
Apr 9 |
Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
|
Apr 8 |
Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
|
Mar 28 |
Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024
|
Mar 5 |
Revolution Medicines files for mixed shelf offering
|
Feb 28 |
Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Revolution Medicines Full Year 2023 Earnings: Misses Expectations
|
Feb 27 |
Q4 2023 Revolution Medicines Inc Earnings Call
|